Biosimilars market Share, Industry Size, Type, Demand, Suppliers and Forecasts 2023

27/nov/2018 09:53:58 orianresearch Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The Global Biosimilars Market was valued at USD XX million in 2016, and is expected to grow at a CAGR of XX% by 2025.  Market is growing by increasing demand for biosimilar drugs due to their cost-effectiveness across the globe.   Rising prevalence of chronic diseases such as cancer and diabetes supplement the growing demands of pharmaceutical drugs could lead to a growth of market in the forecast period. The market growth is favored by growing geriatric population. Awareness and adoption of biosimilars have been rising since the past few years, resulted in the growth of the market. 

Stringent government regulations for the development and production of biosimilars may hinder the adoption of market. Whereas increasing research and development investments, healthcare expenditures and technological advancement is fueling the market in projected year.

For Sample Copy of this Report Visit @ .

Recombinant glycosylated proteins will drive the Biosimilars market in 2017 and have significant growth in the forecasted period. The broad therapeutic area of these proteins and presence of biosimilar versions of monoclonal antibodies at lower prices compared to reference products is expected to fuel the market.  Some of the key players operating in this market include Pfizer, Sandoz International, Teva Pharmaceuticals, Amgen, Beacon, Dr. Reddy’s Laboratories, Celltrion, and Others.

Key Benefits of the Report:

  • Global, Regional, Country, Market Size and Forecast from 2014-2025
  • Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies
  • Identification of key companies that can influence this market on a global and regional scale
  • Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies
  • Detailed insights on emerging regions, Software Type & Product, and competitive landscape with qualitative and quantitative information and facts

Target Audience: 
* Biosimilars providers
* Traders, Importer and Exporter
* Raw material suppliers and distributors
* Research and consulting firms
* Government and research organizations
* Associations and industry bodies

Global Biosimilars Industry is spread across 121 pages, profiling 08 top companies and supported with tables and figures.

Inquire more or share a questions if any before the purchase on this report @

Research Methodology

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics , capacity production, spending were taken into consideration.

We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:

  • Original Equipment Manufacturer
  • Component Supplier
  • Distributors
  • Government Body & Associations
  • Research Institute

Order a copy of Global Biosimilars Market Report 2018 @

1 Executive Summary

2 Methodology And Market Scope

3 Biosimilars Market — Industry Outlook

4 Biosimilars Market Disease Outlook

5 Biosimilars Market Product Outlook

6 Biosimilars Market Regional Outlook

7 Competitive Landscape

End Of The Report


About Us
Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world's most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:        

Ruwin Mendez

Vice President – Global Sales & Partner Relations

Orian Research Consultants

US +1 (415) 830-3727| UK +44 020 8144-71-27



Follow Us on LinkedIn:

blog comments powered by Disqus è un servizio offerto da Factotum Srl